Efficacy and safety study of fotemustine and bevacizumab in patients with recurrent glioblastoma.

被引：0
|
作者：
Escudero, Laura Sanchez [1 ]
Urbano, Maria Amor [1 ]
Garces, Maria Yeray Rodriguez [1 ]
Murillo, Fatima Toscano [1 ]
机构：
[1] Hosp Juan Ramon Jimenez, Huelva, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14041
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy study of retifanlimab and epacadostat in combination with radiation and bevacizumab in patients with recurrent glioblastoma.
    Campian, Jian Li
    Abraham, Christopher
    Luo, Jingqin
    Talcott, Grayson
    Katumba, Ruth
    Kim, Albert H.
    Dunn, Gavin P.
    Ansstas, George
    Johanns, Tanner Michael
    Ciorba, Matthew A.
    Chheda, Milan G.
    Huang, Jiayi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Efficacy and safety of selinexor in recurrent glioblastoma.
    Lassman, Andrew B.
    Wen, Patrick Y.
    Van den Bent, Martin J.
    Plotkin, Scott Randall
    Walenkamp, Anna Maria Elisabeth
    Huang, Xiu
    Rodriguez-Lopez, Karla
    Kauffman, Michael G.
    Shacham, Sharon
    Mau-Sorensen, Morten
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Dose-dependent efficacy of bevacizumab in recurrent glioblastoma.
    Melhem, Jawad
    Tahir, Ali
    Calabrese, Eirena
    Granovskaya, Inga
    Atenafu, Eshetu G.
    Sahgal, Arjun
    Lim-Fat, Mary Jane
    Perry, James R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
    Santoni, Matteo
    Scoccianti, Silvia
    Lolli, Ivan
    Fabrini, Maria Grazia
    Silvano, Giovanni
    Detti, Beatrice
    Perrone, Franco
    Savio, Giuseppina
    Iacovelli, Roberto
    Burattini, Luciano
    Berardi, Rossana
    Cascinu, Stefano
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 113 (03) : 397 - 401
  • [5] Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma
    Matteo Santoni
    Silvia Scoccianti
    Ivan Lolli
    Maria Grazia Fabrini
    Giovanni Silvano
    Beatrice Detti
    Franco Perrone
    Giuseppina Savio
    Roberto Iacovelli
    Luciano Burattini
    Rossana Berardi
    Stefano Cascinu
    [J]. Journal of Neuro-Oncology, 2013, 113 : 397 - 401
  • [6] Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
    Ghiaseddin, Ashley
    Reardon, David A.
    Massey, Woody
    Mannerino, Alexandra
    Lipp, Eric S.
    Herndon, James E.
    McSherry, Frances
    Desjardins, Annick
    Randazzo, Dina M.
    Vlahovic, Gordana
    Friedman, Henry S.
    Peters, Katherine B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] SAFETY AND EFFICACY OF BEVACIZUMAB AND ERLOTINIB FOR RECURRENT GLIOBLASTOMA PATIENTS IN A PHASE II STUDY
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James
    Rich, Jeremy
    Gururangan, Sridharan
    Friedman, Allan
    Friedman, Henry
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 827 - 827
  • [8] AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma
    Brandes, Alba A.
    Finocchiaro, Gaetano
    Zagonel, Vittorina
    Reni, Michele
    Caserta, Claudia
    Fabi, Alessandra
    Clavarezza, Matteo
    Maiello, Evaristo
    Eoli, Marica
    Lombardi, Giuseppe
    Monteforte, Marta
    Proietti, Emanuela
    Agati, Raffaele
    Eusebi, Vincenzo
    Franceschi, Enrico
    [J]. NEURO-ONCOLOGY, 2016, 18 (09) : 1304 - 1312
  • [9] Profiling response to carmustine/bevacizumab in recurrent glioblastoma.
    Rojas, Leonardo
    Cardona, Andres F.
    Wills, Beatriz
    Arrieta, Oscar
    Vargas, Carlos A.
    Carranza, Hernan
    Otero, Jorge M.
    Useche, Nicolas
    Bermudez, Sonia
    Jimenez, Enrique
    Hakim, Fernando
    Balana, Carmen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Safety and efficacy of bevacizumab biosimilar in recurrent/progressive glioblastoma
    Kumar, Gunjesh
    DSouza, Hollis
    Menon, Nandini
    Srinivas, Sujay
    Vallathol, Dilip Harindran
    Boppana, Mounika
    Rajpurohit, Annu
    Mahajan, Abhishek
    Janu, Amit
    Chatterjee, Abhishek
    Krishnatry, Rahul
    Gupta, Tejpal
    Jalali, Rakesh
    Patil, Vijay M.
    [J]. ECANCERMEDICALSCIENCE, 2021, 15
12345